메뉴 건너뛰기
The Lancet
Volumn 387, Issue 10013, 2016, Pages 4-5
Dupilumab: A milestone in the treatment of atopic dermatitis
Author keywords

[No Author keywords available]
Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; DUPILUMAB; EMOLLIENT AGENT; INTERLEUKIN 13; INTERLEUKIN 4; PLACEBO; STEROID; INTERLEUKIN 4 RECEPTOR ALPHA; MONOCLONAL ANTIBODY;
EID: 84954289736     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00389-X     Document Type: Note
Times cited : (23)
References (9)
  • 1
    • 33745361150 scopus 로고    scopus 로고
    • How epidemiology has challenged 3 prevailing concepts about atopic dermatitis
    • H Williams, C Flohr How epidemiology has challenged 3 prevailing concepts about atopic dermatitis J Allergy Clin Immunol 118 2006 209 213
    • (2006) J Allergy Clin Immunol , vol.118 , pp. 209-213
    • Williams, H.1    Flohr, C.2
  • 2
    • 37749025593 scopus 로고    scopus 로고
    • Atopic dermatitis
    • T Bieber Atopic dermatitis N Engl J Med 358 2008 1483 1494
    • (2008) N Engl J Med , vol.358 , pp. 1483-1494
    • Bieber, T.1
  • 4
    • 84883198317 scopus 로고    scopus 로고
    • Immunology of atopic eczema: Overcoming the Th1/Th2 paradigm
    • K Eyerich, N Novak Immunology of atopic eczema: overcoming the Th1/Th2 paradigm Allergy 68 2013 974 982
    • (2013) Allergy , vol.68 , pp. 974-982
    • Eyerich, K.1    Novak, N.2
  • 5
    • 84938150667 scopus 로고    scopus 로고
    • Management of atopic dermatitis: Guideline from the American Academy of Dermatology
    • L Hauk Management of atopic dermatitis: guideline from the American Academy of Dermatology Am Fam Physician 90 2014 798 799
    • (2014) Am Fam Physician , vol.90 , pp. 798-799
    • Hauk, L.1
  • 6
    • 33847240690 scopus 로고    scopus 로고
    • Systemic treatment of severe atopic eczema: A systematic review
    • J Schmitt, K Schäkel, N Schmitt, M Meurer Systemic treatment of severe atopic eczema: a systematic review Acta Derm Venereol 87 2007 100 111
    • (2007) Acta Derm Venereol , vol.87 , pp. 100-111
    • Schmitt, J.1    Schäkel, K.2    Schmitt, N.3    Meurer, M.4
  • 7
    • 33744919804 scopus 로고    scopus 로고
    • IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: Implications for the development of therapeutic targets
    • AL Andrews, JW Holloway, ST Holgate, DE Davies IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets J Immunol 176 2006 7456 7461
    • (2006) J Immunol , vol.176 , pp. 7456-7461
    • Andrews, A.L.1    Holloway, J.W.2    Holgate, S.T.3    Davies, D.E.4
  • 8
    • 84903887689 scopus 로고    scopus 로고
    • Dupilumab treatment in adults with moderate-to-severe atopic dermatitis
    • LA Beck, D Thaçi, JD Hamilton et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis N Engl J Med 371 2014 130 139
    • (2014) N Engl J Med , vol.371 , pp. 130-139
    • Beck, L.A.1    Thaçi, D.2    Hamilton, J.D.3
  • 9
    • 84954271885 scopus 로고    scopus 로고
    • Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: A randomised, placebo-controlled, dose-ranging phase 2b trial
    • published online Oct 8
    • D Thaçi, EL Simpson, LA Beck et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial Lancet 2015 published online Oct 8. http://dx.doi.org/10.1016/S0140-6736(15)00388-8
    • (2015) Lancet
    • Thaçi, D.1    Simpson, E.L.2    Beck, L.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.